The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review

Saved in:
Bibliographic Details
Published inFrontiers in Oncology Vol. 14
Main Authors Yutaka Fujiwara, Kazuhiro Shimomura, Teppei Yamaguchi, Junichi Shimizu, Naohiro Watanabe, Reiko Matsuzawa, Kenta Murotani, Yoshitsugu Horio
Format Journal Article
LanguageJapanese
Published Frontiers Media SA 11.06.2024
Subjects
epidermal growth factor receptor
immune checkpoint inhibitor
interstitial lung disease
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
non-small cell lung cancer
Oncology
pneumonitis
RC254-282
tyrosine kinase inhibitor
Online AccessGet full text

Cover

More Information
ISSN:2234-943X
DOI:10.3389/fonc.2024.1419256